Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1989 1
1991 1
1993 1
1994 1
1995 1
1996 4
1997 3
1998 1
1999 8
2000 12
2001 20
2002 25
2003 21
2004 30
2005 21
2006 27
2007 24
2008 32
2009 29
2010 29
2011 36
2012 35
2013 34
2014 47
2015 44
2016 46
2017 44
2018 52
2019 37
2020 36
2021 53
2022 15
Text availability
Article attribute
Article type
Publication date

Search Results

191 results
Results by year
Filters applied: Review, in the last 5 years. Clear all
Page 1
Pharmacogenomics: A road ahead for precision medicine in psychiatry.
Pardiñas AF, Owen MJ, Walters JTR. Pardiñas AF, et al. Neuron. 2021 Dec 15;109(24):3914-3929. doi: 10.1016/j.neuron.2021.09.011. Epub 2021 Oct 6. Neuron. 2021. PMID: 34619094 Review.
The pharmacogenomics of treatment response encapsulates both pharmacokinetic ("what the body does to a drug") and pharmacodynamic ("what the drug does to the body") effects. ...Nonetheless, advances in genomics and health informatics present distinct opportunities for psyc …
The pharmacogenomics of treatment response encapsulates both pharmacokinetic ("what the body does to a drug") and pharmacodynamic ("w …
Pharmacogenetics in Psychiatry.
Corponi F, Fabbri C, Serretti A. Corponi F, et al. Adv Pharmacol. 2018;83:297-331. doi: 10.1016/bs.apha.2018.03.003. Epub 2018 May 10. Adv Pharmacol. 2018. PMID: 29801579 Review.
This is partly due to the current suboptimal treatment options: existing psychotropic medications, including antidepressants, antipsychotics, and mood stabilizers, are effective only in a subset of patients or produce partial response and they are often associated with debilitati …
This is partly due to the current suboptimal treatment options: existing psychotropic medications, including antidepressants, antipsychotics …
A Review of the Important Role of CYP2D6 in Pharmacogenomics.
Taylor C, Crosby I, Yip V, Maguire P, Pirmohamed M, Turner RM. Taylor C, et al. Genes (Basel). 2020 Oct 30;11(11):1295. doi: 10.3390/genes11111295. Genes (Basel). 2020. PMID: 33143137 Free PMC article. Review.
Cytochrome P450 2D6 (CYP2D6) is a critical pharmacogene involved in the metabolism of ~20% of commonly used drugs across a broad spectrum of medical disciplines including psychiatry, pain management, oncology and cardiology. Nevertheless, CYP2D6 is highly polymorphic with …
Cytochrome P450 2D6 (CYP2D6) is a critical pharmacogene involved in the metabolism of ~20% of commonly used drugs across a broad spectrum of …
Pharmacogenetics in Psychiatry: An Update on Clinical Usability.
van Schaik RHN, Müller DJ, Serretti A, Ingelman-Sundberg M. van Schaik RHN, et al. Front Pharmacol. 2020 Sep 11;11:575540. doi: 10.3389/fphar.2020.575540. eCollection 2020. Front Pharmacol. 2020. PMID: 33041820 Free PMC article. Review.
Using pharmacogenetics in guiding drug therapy experiences a steady increase in uptake, although still leads to discussions as to its clinical use. Psychiatry constitutes a field where pharmacogenomic testing might help in guiding drug therapy. ...
Using pharmacogenetics in guiding drug therapy experiences a steady increase in uptake, although still leads to discussions as to its …
Deep learning in pharmacogenomics: from gene regulation to patient stratification.
Kalinin AA, Higgins GA, Reamaroon N, Soroushmehr S, Allyn-Feuer A, Dinov ID, Najarian K, Athey BD. Kalinin AA, et al. Pharmacogenomics. 2018 May;19(7):629-650. doi: 10.2217/pgs-2018-0008. Epub 2018 Apr 26. Pharmacogenomics. 2018. PMID: 29697304 Free PMC article. Review.
This Perspective provides examples of current and future applications of deep learning in pharmacogenomics, including: identification of novel regulatory variants located in noncoding domains of the genome and their function as applied to pharmacoepigenomics; patient strat …
This Perspective provides examples of current and future applications of deep learning in pharmacogenomics, including: identification …
Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches.
Lin E, Lin CH, Lane HY. Lin E, et al. Int J Mol Sci. 2020 Feb 1;21(3):969. doi: 10.3390/ijms21030969. Int J Mol Sci. 2020. PMID: 32024055 Free PMC article. Review.
A growing body of evidence now suggests that precision psychiatry, an interdisciplinary field of psychiatry, precision medicine, and pharmacogenomics, serves as an indispensable foundation of medical practices by offering the accurate medication with the accu …
A growing body of evidence now suggests that precision psychiatry, an interdisciplinary field of psychiatry, precision medicin …
Consequences of CYP2D6 Copy-Number Variation for Pharmacogenomics in Psychiatry.
Jarvis JP, Peter AP, Shaman JA. Jarvis JP, et al. Front Psychiatry. 2019 Jun 20;10:432. doi: 10.3389/fpsyt.2019.00432. eCollection 2019. Front Psychiatry. 2019. PMID: 31281270 Free PMC article. Review.
Pharmacogenomics represents a potentially powerful enhancement to the current standard of care for psychiatric patients. ...We discuss best practices for overcoming these challenges and then explore various current and future applications of pharmacogenomic analysis
Pharmacogenomics represents a potentially powerful enhancement to the current standard of care for psychiatric patients. ...We discus
The role of genetics and genomics in clinical psychiatry.
Hoehe MR, Morris-Rosendahl DJ. Hoehe MR, et al. Dialogues Clin Neurosci. 2018 Sep;20(3):169-177. doi: 10.31887/DCNS.2018.20.3/mhoehe. Dialogues Clin Neurosci. 2018. PMID: 30581286 Free PMC article. Review.
Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).
Del Casale A, Sorice S, Padovano A, Simmaco M, Ferracuti S, Lamis DA, Rapinesi C, Sani G, Girardi P, Kotzalidis GD, Pompili M. Del Casale A, et al. Curr Neuropharmacol. 2019;17(8):710-736. doi: 10.2174/1570159X16666180813155017. Curr Neuropharmacol. 2019. PMID: 30101713 Free PMC article. Review.
The addition of medications other than antipsychotics or intravenous antidepressant administration needs further investigation, as the evidence is inconsistent. Pharmacogenomics and personalization of therapy could reduce treatment resistance. ...New strategies for refract …
The addition of medications other than antipsychotics or intravenous antidepressant administration needs further investigation, as the evide …
Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry.
Amare AT, Schubert KO, Baune BT. Amare AT, et al. EPMA J. 2017 Sep 5;8(3):211-227. doi: 10.1007/s13167-017-0112-8. eCollection 2017 Sep. EPMA J. 2017. PMID: 29021832 Free PMC article. Review.
In this review, we summarize pharmacogenomic studies in mood disorders that may lay the foundation towards personalized psychiatry. ...An integration of molecular science with that of traditional clinical practice is the way forward to drug discoveries and novel the …
In this review, we summarize pharmacogenomic studies in mood disorders that may lay the foundation towards personalized psychiatry
191 results